Future studies should evaluate whether multiple measurements of FGF23 may be advantageous compared to a single measurement for individual patients risk assessment in those with CKD, as it was shown that especially increasing FGF23 concentrations over time are associated with increased mortality [58, 59]. This evidence concerns the gene FGF23 and chronic kidney disease.